Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lazanda for Anxiolysis During Lumbar Facet RFA
NCT02571634Phase 4Completed
- Sponsor
- Defense and Veterans Center for Integrative Pain Management
- Start
- May 2015
- Primary completion
- Jan 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fentanyl in procedural pain and Procedural anxiety, sponsored by Defense and Veterans Center for Integrative Pain Management. Primary endpoint: Safety and Tolerability as Measured by the Number of Adverse Events at 24 hours. Started May 2015; status: completed.
02
Drugs
fentanyl
03
Conditions
procedural painProcedural anxiety
Beyond the preview
Go deeper on NCT02571634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02571634.